Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00698165 · ClinicalTrials.gov registry record
Observational Study on Costs and Caregiver Burden in Alzheimer's Disease
A clinical trial of Alzheimers Disease, sponsored by AstraZeneca.
- Completed
- Registry status
- 2,400
- Enrollment target
- 20
- Study locations
NCT00698165: Completed study of Alzheimers Disease, sponsored by AstraZeneca.
NCT00698165 is a study of Alzheimers Disease that has completed, run by AstraZeneca. The registered enrollment target is 2,400 participants, below the 3,910-participant average among 147 other Alzheimers Disease trials with a reported enrollment target (39% lower). The trial reports 20 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00698165, a study of Alzheimers Disease, has completed, sponsored by AstraZeneca.
- COMPLETED
- Registry status
- 2,400 participants
- Enrollment target
- 20
- Study locations
Study Summary
Objective of study is to assess the costs of care, objective and subjective caregiver burden and quality of life in relation to disease severity measured by cognitive function, ADL capabilities and presence of behavioral disturbances in Alzheimer's disease
Conditions Studied
Study Locations (20)
Florida
- Research Site - Atlantis
- Research Site - Fort Myers
- Research Site - Miami
- Research Site - Port Charlotte
- Research Site - Tampa
- Research Site - Titusville
- Research Site - Venice
Georgia
- Research Site - Canton
- Research Site - Columbus
- Research Site - Decatur
- Research Site - Dunwoody
- Research Site - Snellville
California
- Research Site - Brentwood
- Research Site - Fresno
- Research Site - La Habra
- Research Site - Long Beach
Alabama
- Research Site - Northport
Arizona
- Research Site - Phoenix
Colorado
- Research Site - Denver
Connecticut
- Research Site - Wetherfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,400 participants |
| Start Date | 2007-06 |
| Est. Completion | 2009-01 |
What the finished NCT00698165 record still lists
NCT00698165 is an observational study that tracks outcomes without assigning an intervention. Its 2,400 participants enrollment target places it among the larger protocols in the corpus, below the 3,910-participant average among 147 other Alzheimers Disease trials with a reported enrollment target (39% lower).
The record links to 1 condition, with Alzheimers Disease appearing as the primary indexed condition, and to 0 interventions.
NCT00698165 names 20 study sites across 7 states, led by Florida, Georgia, California.
Frequently Asked Questions
What is clinical trial NCT00698165 about?
NCT00698165 is a clinical study titled "Observational Study on Costs and Caregiver Burden in Alzheimer's Disease". Objective of study is to assess the costs of care, objective and subjective caregiver burden and quality of life in relation to disease severity measured by cognitive function, ADL capabilities and presence of behavioral disturbances in Alzheimer's disease
What is the current status of trial NCT00698165?
This trial is currently completed. The enrollment target is 2,400 participants. The study started on 2007-06. Estimated completion is 2009-01.
What conditions does trial NCT00698165 study?
This clinical trial studies the following conditions: Alzheimers Disease.
Who is sponsoring clinical trial NCT00698165?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00698165 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimers Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00698165's enrollment target sits among peer trials
2,400 6th of 147 higher than 142 of 147 other Alzheimers Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alzheimers Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
RECRUITING · Phase 3
-
Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease
RECRUITING · Phase 2
-
University of Central Florida Music Study
RECRUITING · NA
-
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
RECRUITING · Phase 2
-
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
RECRUITING · Phase 3
-
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05185440 · 2,400 participants · NA
Reducing Alcohol Involved Sexual Violence in Higher Education
- NCT05285527 · 2,400 participants · NA
MiSight 1 Day Safety Post-Approval Study
- NCT05738330 · 2,400 participants · NA
Symptom Monitoring in Hemodialysis
- NCT05833360 · 2,400 participants
Prospective Study of oncRNA Stratification of Cancer by Size and Stage
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia